5-[5-(1-acetylpyrrolidin-3-yl)oxy-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)-4H-pyridazin-3-one
C19H18F4N4O3 — CID 154825724
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[5-(1-acetylpyrrolidin-3-yl)oxy-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)-4H-pyridazin-3-one
5-[5-(1-acetylpyrrolidin-3-yl)oxy-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)-4H-pyridazin-3-one (PubChem CID 154825724) has the molecular formula C19H18F4N4O3 and a molecular weight of 426.37 g/mol. Its IUPAC name is 5-[5-(1-acetylpyrrolidin-3-yl)oxy-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)-4H-pyridazin-3-one.
Molecular Properties
| Compound Name | 5-[5-(1-acetylpyrrolidin-3-yl)oxy-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)-4H-pyridazin-3-one |
|---|---|
| PubChem CID | 154825724 |
| Molecular Formula | C19H18F4N4O3 |
| Molecular Weight | 426.37 g/mol |
| Exact Mass | 426.13 |
| IUPAC Name | 5-[5-(1-acetylpyrrolidin-3-yl)oxy-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)-4H-pyridazin-3-one |
| SMILES | CC(=O)N1CCC(Oc2cc3c(cc2F)CN(C2=CN=NC(=O)C2C(F)(F)F)C3)C1 |
| InChI | InChI=1S/C19H18F4N4O3/c1-10(28)26-3-2-13(9-26)30-16-5-12-8-27(7-11(12)4-14(16)20)15-6-24-25-18(29)17(15)19(21,22)23/h4-6,13,17H,2-3,7-9H2,1H3 |
| InChIKey | KYPIKWQGVURKQW-UHFFFAOYSA-N |
| XLogP | 3.15 |
| TPSA | 74.57 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 426.37 |
| LogP ≤ 5 | 3.15 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154825724 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.